Myomo Inc (MYO)

Myomo, Inc. is a healthcare equipment and supplies company focused on wearable medical robotics. The company develops and manufactures myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and other international markets. Its product line includes MyoPro, a myoelectric-controlled upper limb brace designed to support a weak or paralyzed arm and assist daily activities, along with MyoPro 2, which adds control technology, configuration software, a user interface, and a pop-out battery for longer use. Myomo also offers MyoPro2+, MyoGames, and the MyoPro 2x Video Library, as well as MyoCare, a post-delivery support program for clients, therapists, and referral sources. The company serves adults and adolescents with conditions related to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. Founded in 2004, Myomo is headquartered in Burlington, Massachusetts, and its common stock trades on the NYSE under the symbol MYO.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-MYO
$1.49
-8.9% Downside
Fair
$4.64
182.9% Upside
Bargain
Good
0.0%
November 11, 2026
11.1x
1.5x
64.957 M
71.585 M
24.4%
70.4%
-3.3
57.4%
Valuation • Fair Value

Myomo Inc (NYSE-MYO) Fair Value by Valuation Model

Review the available estimates for Myomo Inc (NYSE-MYO), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.49

Estimated downside of 8.9% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$1.78

Discounted cash flow valuation reference.

EPV Fair Value

$1.25

Earnings power value estimate.

Comps Fair Value

$1.44

Comparable-company valuation reference.

Analyst Price Target

$4.64

Analysts imply upside of 182.9%.

How to read these valuation models

Use the 6 available valuation references for Myomo Inc (NYSE-MYO) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Myomo Inc (NYSE-MYO)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

43.262 M

Current operating scale indicator.

Revenue Forecast

46 M

Forward revenue estimate.

EBITDA

-10.517 M

Current operating profitability reference.

EBITDA Forecast

-5.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Myomo Inc (NYSE-MYO) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Myomo Inc (NYSE-MYO)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

-2.77

No elevated caution signal from this screen.

Altman Z-Score

-3.3

Lower score that deserves closer risk review.

FCF / Net Income

57.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Myomo Inc (NYSE-MYO). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Myomo Inc (NYSE-MYO)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 11, 2026

Days to Earnings

50

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Myomo Inc (NYSE-MYO), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Myomo Inc (NYSE-MYO) Stock Forecast & Technical Outlook

Review Myomo Inc (NYSE-MYO) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Myomo Inc (NYSE-MYO) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Myomo Inc (NYSE-MYO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Myomo Inc (NYSE-MYO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Myomo Inc (NYSE-MYO) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Myomo Inc (NYSE-MYO) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Myomo Inc (NYSE-MYO)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Myomo Inc (NYSE-MYO) has a Strong Buy consensus, with 4 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 0
Sell 0
FAQ Fast Investor Answers

Myomo Inc (NYSE-MYO) Stock FAQ

Data-supported answers about Myomo Inc (NYSE-MYO), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.49
Estimated downside 8.9%
Valuation Rating
Overvalued
Estimated downside of 8.9%
Analyst Target
$4.64
Implied upside 182.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for Myomo Inc (NYSE-MYO) is $1.49. This implies an estimated downside of 8.9% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 8.9% versus the current market price.

The available analyst price target for Myomo Inc (NYSE-MYO) is $4.64. The analyst target implies estimated upside of 182.9%.

The current financial health read for Myomo Inc (NYSE-MYO) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Myomo Inc (NYSE-MYO) is November 11, 2026.

The latest available data indicates no current dividend yield for Myomo Inc (NYSE-MYO).

The current market capitalization listed for Myomo Inc is 64.957 M.

The current enterprise value listed for Myomo Inc is 71.585 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Myomo Inc is NYSE-MYO, and the stock is listed on NYSE.

Myomo Inc (NYSE-MYO) is listed on NYSE.

The current debt-to-total-capital ratio listed for Myomo Inc is 24.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Myomo Inc is 70.4%. Free float helps investors understand how much of the share base is available for public trading.